, Tracking Stock Market Picks
Enter Symbol:
Affymax, Inc. (AFFY) [hlAlert]

down 99.69 %

Affymax, Inc. (AFFY) rated Outperform with price target $30 by RBC Capital Mkts

Posted on: Friday,  Mar 14, 2008  9:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Affymax, Inc. (OTCBB: AFFY) on 03/14/2008. Previously RBC Capital Mkts rated Buy Affymax, Inc. (OTCBB: AFFY) on
07/17/2007., when the stock price was $28.19. Since then, Affymax, Inc. has lost 99.69% as of 08/27/2015's recent price of $0.09.
If you would have followed the previous RBC Capital Mkts's recommendation on AFFY, you would have lost 99.69% of your investment in 2963 days.

Affymax, Inc. is a biopharmaceutical company developing peptide-based drugs to improve the treatment of serious and often life-threatening conditions. The Company's product candidate, Hematide, is designed to treat anemia associated with chronic renal failure. Hematide is a relatively small synthetic peptide-based erythropoiesis stimulating agent (ESA), which it is developing for the treatment of anemia patients with chronic renal failure. The Company is conducting Phase III clinical trials in patients suffering from chronic renal renal failure, on dialysis and not on dialysis (pre-dialysis). In August 2008, the Company and Takeda Pharmaceutical Company Limited (Takeda), agreed to suspend development of Hematide to treat chemotherapy induced anemia.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/14/2008 9:25 AM Buy
15.89 30.00
as of 12/24/2008
1 Week down  -3.73 %
1 Month up  9.24 %
3 Months up  55.68 %
1 YTD up  72.67 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/17/2007 9:25 AM Buy
28.19 40.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy